EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine

Stefano Ministrini iD, Teresa Padro iD

European Journal of Clinical Investigation · 2024

DOI: 10.1111/eci.14223 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, 2024. Verfasst von Stefano Ministrini und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Precision Medicine, MicroRNAs, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 109 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Personalized medicine represents a novel and integrative approach that focuses on an individual's genetics and epigenetics, precision medicine, lifestyle and exposures as key players of health status and disease phenotypes.

Methods

In this narrative review, we aim to carefully discuss the current knowledge on gender disparities in cardiometabolic diseases, and we consider the sex‐ specific expression of miRNAs and their role as promising tool in precision medicine.

Results

Personalised medicine overcomes the restricted care of patient based on a binomial sex approach, by enriching itself with a holistic and dynamic gender integration. Recognized as a major worldwide health emergency, cardiometabolic disorders continue to rise, impacting on health systems and requiring more effective and targeted strategies. Several sex and gender drivers might affect the onset and progression of cardiometabolic disorders in males and females at multiple levels. In this respect, distinct contribution of genetic and epigenetic mechanisms, molecular and physiological pathways, sex hormones, visceral fat and subcutaneous fat and lifestyle lead to differences in disease burden and outcomes in males and females.

Conclusions

Sex and gender play a pivotal role in precision medicine because the influence the physiology of each individual and the way they interact with environment from intrauterine life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineMicroRNAsCardiovascular DiseasesHumansMaleFemaleSex FactorsMetabolic DiseasesEpigenesis, GeneticLife Style

Stichwörter der Autor:innen

epigeneticsgender medicinemiRNAnon‐coding RNAsprecision medicinesex differences

Substanzen

MicroRNAs

Autor:innen und Institutionen

  • Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
  • Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Barcelona, Spain.
  • Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV) Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Stefano Ministrini, Teresa Padro

Zitieren

APA

Ministrini, S., & Padro, T. (2024). MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.14223

Vancouver

Ministrini S, Padro T. MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine. European Journal of Clinical Investigation. 2024. doi:10.1111/eci.14223

BibTeX
@article{Ministrini2024,
  author = {Ministrini, Stefano and Padro, Teresa},
  title = {MicroRNA in cardiometabolic health and disease: The perspectives of sex, gender and personalised medicine},
  journal = {European Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1111/eci.14223}
}
Kostenlos starten →